Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home
Share
Compartir

 

Sexually Transmitted Diseases Treatment Guidelines, 2010
Table 4. Interpretation of serologic test results* for HBV infection


Serologic marker Interpretation
HBsAg† Total anti-HBc§ IgM¶ anti-HBc Anti-HBs**
- - - - Never infected
+†† - - - Early acute infection; transient (up to 18 days) after vaccination
+ + + - Acute infection
- + + - Acute resolving infection
- + - + Recovered from past infection and immune
+ + - - Chronic infection
- + - - False positive (i.e., susceptible); past infection; “low-level” chronic infection§§; passive transfer to infant born to HBsAg-positive mother
- - - + Immune if concentration is >10 mIU/mL,¶¶ passive transfer after HBIG administration

* Symbol for negative test result, “–“; symbol for positive test result, “+”.
† Hepatitis B surface antigen.
§ Antibody to hepatitis B core antigen.
¶ Immunoglobulin M.
** Antibody to HBsAg.
†† To ensure that an HBsAg-positive test result is not a false positive, samples with repeatedly reactive HBsAg results should be tested with an FDA-cleared (and, if appropriate, neutralizing confirmatory) test.
§§ Persons positive for only anti-HBc are unlikely to be infectious except under unusual circumstances involving direct percutaneous exposure to large quantities of blood (e.g., blood transfusion and organ transplantation).
¶¶ Milli-International Units per milliliter.

 

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #